Yüklüyor......
Sodium-glucose co-transporter-2 drugs: are we sure they are useful only in the treatment of diabetes?
The sodium-glucose co-transporter-2 (SGLT2) inhibitors are a new class of oral anti-diabetic drugs acting through the inhibition of renal reabsorbtion of glucose. Three important randomized clinical trial in diabetic patients receiving SGLT2 inhibitors (vs. placebo), demonstrated a significant reduc...
Kaydedildi:
| Yayımlandı: | Eur Heart J Suppl |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7904067/ https://ncbi.nlm.nih.gov/pubmed/33654470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/suaa138 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|